MiMedx Group (MDXG) Reports Q4 Loss of $0.17/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to MiMedx Group (MDXG) Reports Q4 Loss of $0.17/sh

MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results

March 8, 2021 5:32 PM EST

Fourth Quarter Net Sales of $68.5 million, Full Year 2020 Net Sales of $248.2 million

Company to Host Conference Call on March 9, 2021 at 9:30 AM ET

MARIETTA, Ga., March 08, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MiMedx or the Company), an industry leader in utilizing birth tissue as a platform for regenerative medicine, today announced the filing of its 2020 Annual Report on Form 10-K for the period ended December 31, 2020.

Timothy R. Wright, MiMedx Chief Executive Officer, commented, 2020 was a foundational year for MiMedx, with significant accomplishments of... More